Avestar Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
4,111
+253
| +7% | +$113K | 0.13% | 114 |
|
|
2025
Q1 | $1.87M | Buy |
3,858
+184
| +5% | +$89.2K | 0.16% | 95 |
|
|
2024
Q4 | $1.48M | Buy |
3,674
+518
| +16% | +$209K | 0.13% | 114 |
|
|
2024
Q3 | $1.47M | Buy |
3,156
+104
| +3% | +$48.4K | 0.15% | 104 |
|
|
2024
Q2 | $1.43M | Buy |
3,052
+148
| +5% | +$69.4K | 0.15% | 103 |
|
|
2024
Q1 | $1.21M | Buy |
2,904
+694
| +31% | +$290K | 0.13% | 117 |
|
|
2023
Q4 | $899K | Buy |
2,210
+237
| +12% | +$96.4K | 0.1% | 116 |
|
|
2023
Q3 | $686K | Buy |
1,973
+23
| +1% | +$8K | 0.1% | 121 |
|
|
2023
Q2 | $686K | Sell |
1,950
-1
| -0.1% | -$352 | 0.11% | 99 |
|
|
2023
Q1 | $615K | Buy |
1,951
+629
| +48% | +$198K | 0.11% | 112 |
|
|
2022
Q4 | $382K | Sell |
1,322
-63
| -5% | -$18.2K | 0.07% | 153 |
|
|
2022
Q3 | $401K | Sell |
1,385
-319
| -19% | -$92.4K | 0.1% | 135 |
|
|
2022
Q2 | $480K | Sell |
1,704
-4,711
| -73% | -$1.33M | 0.12% | 107 |
|
|
2022
Q1 | $1.67M | Buy |
6,415
+4,886
| +320% | +$1.28M | 0.27% | 64 |
|
|
2021
Q4 | $336K | Sell |
1,529
-98
| -6% | -$21.5K | 0.04% | 255 |
|
|
2021
Q3 | $295K | Buy |
1,627
+128
| +9% | +$23.2K | 0.04% | 274 |
|
|
2021
Q2 | $302K | Buy |
1,499
+207
| +16% | +$41.7K | 0.04% | 258 |
|
|
2021
Q1 | $276K | Buy |
1,292
+92
| +8% | +$19.7K | 0.06% | 261 |
|
|
2020
Q4 | $284K | Buy |
1,200
+187
| +18% | +$44.3K | 0.08% | 223 |
|
|
2020
Q3 | $210K | Buy |
1,013
+220
| +28% | +$45.6K | 0.07% | 209 |
|
|
2020
Q2 | $230K | Buy |
+793
| New | +$230K | 0.1% | 159 |
|
|
2019
Q3 | – | Sell |
-674
| Closed | -$107K | – | 828 |
|
|
2019
Q2 | $107K | Buy |
674
+114
| +20% | +$18.1K | 0.07% | 181 |
|
|
2019
Q1 | $86K | Sell |
560
-50
| -8% | -$7.68K | 0.06% | 212 |
|
|
2018
Q4 | $75K | Sell |
610
-55
| -8% | -$6.76K | 0.05% | 215 |
|
|
2018
Q3 | $107K | Buy |
665
+38
| +6% | +$6.11K | 0.06% | 190 |
|
|
2018
Q2 | $91K | Buy |
627
+153
| +32% | +$22.2K | 0.06% | 207 |
|
|
2018
Q1 | $57K | Buy |
474
+63
| +15% | +$7.58K | 0.04% | 236 |
|
|
2017
Q4 | $45K | Buy |
+411
| New | +$45K | 0.03% | 263 |
|